No profile data available.
Big Pharma Split Corp. (PRM.TO) is a financial services company in the multi-strategy investment services industry.
It reported revenue of 435,082 CAD for fiscal year 2024, up 39.6% from fiscal year 2023, and net income of -538,624 CAD. Its market capitalization was 19.13 million CAD as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
Big Pharma Split reported 435,082 CAD in revenue for fiscal year 2024, up 39.6% from 311,760 CAD in fiscal year 2023.
19.13 million CAD as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-strategy investment services) include Precious Metals and Mining Trust (MMP-UN.TO), Culico Metals INC (CLCO.V), Premium Global Income Split Corp. (PGIC.TO), New Commerce Split Fund (YCM.TO).